Our findings indicate that the engineered LHRH-BinBC toxin has specific cytotoxicity against LHRH-positive cells in vitro (MCF-7 cells) and may induce cell death via apoptosis, making this engineered Bin protein a potential alternative for targeted breast cancer therapy. The gene discussed is GNRH1; the disease is breast carcinoma.